Galunisertib has been used in trials studying the basic science and treatment of Glioma, Neoplasms, Solid Tumor, GLIOBLASTOMA, and Prostate Cancer, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.